Excelsior Biopharma Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 367.979 million compared to TWD 362.731 million a year ago. Operating income was TWD 11.281 million compared to TWD 21.257 million a year ago. Net income was TWD 8.313 million compared to TWD 14.806 million a year ago. Basic earnings per share was TWD 0.18 compared to TWD 0.32 a year ago. For the nine months, sales was TWD 1,099.962 million compared to TWD 1,116.387 million a year ago. Operating income was TWD 43.597 million compared to TWD 63.350 million a year ago. Net income was TWD 31.673 million compared to TWD 47.220 million a year ago. Basic earnings per share was TWD 0.68 compared to TWD 1.01 a year ago. Diluted earnings per share was TWD 0.67 compared to TWD 1.01 a year ago.